F. Kommoss

4.2k total citations · 1 hit paper
87 papers, 1.5k citations indexed

About

F. Kommoss is a scholar working on Reproductive Medicine, Obstetrics and Gynecology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, F. Kommoss has authored 87 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Reproductive Medicine, 24 papers in Obstetrics and Gynecology and 19 papers in Pulmonary and Respiratory Medicine. Recurrent topics in F. Kommoss's work include Ovarian cancer diagnosis and treatment (27 papers), Endometrial and Cervical Cancer Treatments (19 papers) and Sarcoma Diagnosis and Treatment (10 papers). F. Kommoss is often cited by papers focused on Ovarian cancer diagnosis and treatment (27 papers), Endometrial and Cervical Cancer Treatments (19 papers) and Sarcoma Diagnosis and Treatment (10 papers). F. Kommoss collaborates with scholars based in Germany, Canada and United States. F. Kommoss's co-authors include Stefan Kommoss, Annette Staebler, Jessica N. McAlpine, Anthony N. Karnezis, David G. Huntsman, C. Blake Gilks, Aline Talhouk, Samuel Leung, Amy Lum and S Brücker and has published in prestigious journals such as Cancer Research, Clinical Cancer Research and British Journal of Cancer.

In The Last Decade

F. Kommoss

75 papers receiving 1.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Final validation of the ProMisE molecular classifier for endometrial carcinoma in a large population-based case series

2018 490 citations Stefan Kommoss, F. Kommoss et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
F. Kommoss Germany	16	760	626	310	299	283	87	1.5k
Soon‐Beom Kang South Korea	24	778 1.0×	692 1.1×	188 0.6×	277 0.9×	354 1.3×	64	1.5k
Kazuhiro Takehara Japan	24	736 1.0×	805 1.3×	296 1.0×	305 1.0×	461 1.6×	133	1.8k
Wataru Yamagami Japan	24	763 1.0×	703 1.1×	149 0.5×	473 1.6×	641 2.3×	124	2.0k
Darren Wheeler United States	15	397 0.5×	560 0.9×	164 0.5×	167 0.6×	262 0.9×	30	1.1k
Yuko Sasajima Japan	19	328 0.4×	251 0.4×	225 0.7×	358 1.2×	375 1.3×	94	1.2k
Katsuhiko Hasumi Japan	27	905 1.2×	778 1.2×	167 0.5×	387 1.3×	377 1.3×	112	1.9k
Inge C. van Gool Netherlands	12	389 0.5×	238 0.4×	231 0.7×	270 0.9×	495 1.7×	13	1.3k
G. Baiocchi Italy	25	713 0.9×	721 1.2×	131 0.4×	259 0.9×	382 1.3×	53	1.6k
Natalja T. ter Haar Netherlands	26	513 0.7×	436 0.7×	184 0.6×	700 2.3×	677 2.4×	51	2.1k
JL BENEDET Italy	8	1.4k 1.8×	1.4k 2.3×	184 0.6×	377 1.3×	427 1.5×	8	2.4k

Countries citing papers authored by F. Kommoss

Since Specialization

Citations

This map shows the geographic impact of F. Kommoss's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Kommoss with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Kommoss more than expected).

Fields of papers citing papers by F. Kommoss

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F. Kommoss. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Kommoss. The network helps show where F. Kommoss may publish in the future.

Co-authorship network of co-authors of F. Kommoss

This figure shows the co-authorship network connecting the top 25 collaborators of F. Kommoss. A scholar is included among the top collaborators of F. Kommoss based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F. Kommoss. F. Kommoss is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Almadani, Noorah, Rebecca Ho, F. Kommoss, et al.. (2025). Prognostic values of molecular subtypes and SWI/SNF protein expression in de‐differentiated/undifferentiated endometrial carcinoma. Histopathology. 86(7). 1053–1063. 1 indexed citations

Lang, Jessica D., Anthony N. Karnezis, F. Kommoss, et al.. (2025). Super-enhancers and efficacy of triptolide in small cell carcinoma of the ovary hypercalcemic type. iScience. 28(2). 111770–111770.

Aguado, M. Teresa, Teresa Ramón y Cajal, Alberto Gallardo, et al.. (2024). Non-C19MC-altered embryonal tumor with multilayered rosettes in a young woman with DICER1 syndrome: case report and review of the literature. Pathologica. 116(3). 170–175.

Wang, Yemin, Janine Senz, Winnie Yang, et al.. (2023). Biallelic Dicer1 Mutations in the Gynecologic Tract of Mice Drive Lineage-Specific Development of DICER1 Syndrome–Associated Cancer. Cancer Research. 83(21). 3517–3528. 5 indexed citations

Benabdallah, Nezha S., R. Wilder Scott, F. Kommoss, et al.. (2023). Aberrant gene activation in synovial sarcoma relies on SSX specificity and increased PRC1.1 stability. Nature Structural & Molecular Biology. 30(11). 1640–1652. 11 indexed citations

Kommoss, F., Anne‐Sophie Chong, María Apellániz-Ruiz, et al.. (2023). Teratoma‐associated and so‐called pure Wilms tumour of the ovary represent two separate tumour types with distinct molecular features. Histopathology. 84(4). 683–696. 2 indexed citations

Tessier‐Cloutier, Basile, F. Kommoss, David L. Kolin, et al.. (2023). Dedifferentiated and Undifferentiated Ovarian Carcinoma: An Aggressive and Molecularly Distinct Ovarian Tumor Characterized by Frequent SWI/SNF Complex Inactivation. Modern Pathology. 37(1). 100374–100374. 10 indexed citations

Kommoss, F., Brooke E. Howitt, Krisztina Hanley, et al.. (2023). High-Grade Endometrial Stromal Sarcomas With YWHAE::NUTM2 Gene Fusion Exhibit Recurrent CDKN2A Alterations and Absence of p16 Staining is a Poor Prognostic Marker. Modern Pathology. 36(3). 100044–100044. 13 indexed citations

Koelsche, Christian, Jamal Benhamida, F. Kommoss, et al.. (2021). Intimal sarcomas and undifferentiated cardiac sarcomas carry mutually exclusive MDM2, MDM4, and CDK6 amplifications and share a common DNA methylation signature. Modern Pathology. 34(12). 2122–2129. 24 indexed citations

10.

Sies, Katharina, Julia K. Winkler, Christine Fink, et al.. (2021). Auswirkungen des „dunklen Rand‐Artefakts“ in dermatoskopischen Bildern auf die diagnostische Leistungsfähigkeit eines deep learning neuronalen Netzwerkes mit Marktzulassung. JDDG Journal der Deutschen Dermatologischen Gesellschaft. 19(6). 842–851.

11.

Kommoss, F., Thomas Mentzel, Dietmar Schmidt, et al.. (2021). Spindle Cell Sarcoma of the Uterine Corpus With Adipose Metaplasia: Expanding the Morphologic Spectrum of Neoplasms With MEIS1-NCOA2 Gene Fusion. International Journal of Gynecological Pathology. 41(4). 417–422. 10 indexed citations

12.

Kommoss, F., Damian Stichel, Jaume Mora, et al.. (2021). Clinicopathologic and molecular analysis of embryonal rhabdomyosarcoma of the genitourinary tract: evidence for a distinct DICER1-associated subgroup. Modern Pathology. 34(8). 1558–1569. 35 indexed citations

13.

Bolkestein, Michiel, John Wong, Verena Thewes, et al.. (2020). Chromothripsis in Human Breast Cancer. Cancer Research. 80(22). 4918–4931. 17 indexed citations

14.

Kommoss, F., Kenneth Tou En Chang, Damian Stichel, et al.. (2020). Endometrial stromal sarcomas with BCOR‐rearrangement harbor MDM2 amplifications. The Journal of Pathology Clinical Research. 6(3). 178–184. 36 indexed citations

15.

Kommoss, F., Constantin Schwab, Willi L. Wagner, et al.. (2020). The Pathology of Severe COVID-19-Related Lung Damage. Deutsches Ärzteblatt international. 117(29-30). 500–506. 67 indexed citations

16.

Kommoss, F., et al.. (2019). Keimstrang-Stromatumoren des Ovars: Aktuelle Aspekte, insbesondere zu Granulosazelltumoren, Sertoli-Leydig-Zell-Tumoren und Gynandroblastomen. Der Pathologe. 40(1). 61–72.

17.

Wagner, Philipp, F. Kommoss, Stefan Kommoss, et al.. (2019). Unexpected malignant uterine pathology: Incidence, characteristics and outcome in a large single-center series of hysterectomies for presumed benign uterine disease. Gynecologic Oncology. 153(1). 49–54. 10 indexed citations

18.

Kommoss, Stefan, F. Kommoss, Joachim Diebold, et al.. (2016). Better resource utilisation and quality of care for ovarian cancer patients using internet-based pathology review. British Journal of Cancer. 116(3). 287–292. 1 indexed citations

19.

Wetzka, B., et al.. (1994). Immunohistochemical localization of throm☐ane synthase in human intrauterine tissues. Placenta. 15(4). 389–398. 18 indexed citations

20.

Thompson, John A., Volker L. Reichardt, Nicole Beauchemin, et al.. (1993). A polymerase‐chain‐reaction assay for the specific identification of transcripts encoded by individual carcinoembryonic antigen (CEA)‐gene‐family members. International Journal of Cancer. 55(2). 311–319. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact